These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17721276)

  • 21. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
    Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
    J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib.
    Clark GM; Zborowski DM; Culbertson JL; Whitehead M; Savoie M; Seymour L; Shepherd FA
    J Thorac Oncol; 2006 Oct; 1(8):837-46. PubMed ID: 17409968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.
    Allo G; Bandarchi B; Yanagawa N; Wang A; Shih W; Xu J; Dalby M; Nitta H; To C; Liu N; Sykes J; Tsao MS
    Histopathology; 2014 May; 64(6):826-39. PubMed ID: 24251405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
    Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
    Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas.
    Ensinger C; Spizzo G; Moser P; Tschoerner I; Prommegger R; Gabriel M; Mikuz G; Schmid KW
    Ann N Y Acad Sci; 2004 Dec; 1030():69-77. PubMed ID: 15659782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
    Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
    Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parotid carcinoma: expression of kit protein and epidermal growth factor receptor.
    Sørensen KB; Godballe C; de Stricker K; Krogdahl A
    J Oral Pathol Med; 2006 May; 35(5):286-91. PubMed ID: 16630292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancer.
    Perkins G; Lièvre A; Ramacci C; Méatchi T; de Reynies A; Emile JF; Boige V; Tomasic G; Bachet JB; Bibeau F; Bouché O; Penault-Llorca F; Merlin JL; Laurent-Puig P
    Int J Cancer; 2010 Sep; 127(6):1321-31. PubMed ID: 20049837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of HER2 immunohistochemical results using a monoclonal antibody (SV2-61γ) and a polyclonal antibody (for Dako HercepTest) in advanced gastric cancer.
    Tamura G; Osakabe M; Yanagawa N; Ogata SY; Nomura T; Fukushima N; Ito Y; Tabuchi M
    Pathol Int; 2012 Aug; 62(8):513-7. PubMed ID: 22827758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.
    Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
    Int J Oncol; 2005 Aug; 27(2):317-25. PubMed ID: 16010411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections.
    Atkins D; Reiffen KA; Tegtmeier CL; Winther H; Bonato MS; Störkel S
    J Histochem Cytochem; 2004 Jul; 52(7):893-901. PubMed ID: 15208356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.
    Lu Y; Li X; Liang K; Luwor R; Siddik ZH; Mills GB; Mendelsohn J; Fan Z
    Cancer Res; 2007 Sep; 67(17):8240-7. PubMed ID: 17804738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of epidermal growth factor receptor in colorectal adenocarcinoma by enzyme immunoassay.
    Messa C; Russo F; Notarnicola M; Di Leo A
    Digestion; 1994; 55(2):103-7. PubMed ID: 8187972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
    Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor α.
    Badve S; Vladislav IT; Spaulding B; Strickland A; Hernandez S; Bird-Turner L; Dodson C; Elleby B; Phillips T
    J Clin Pathol; 2013 Dec; 66(12):1051-7. PubMed ID: 23894168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissues.
    Derecskei K; Moldvay J; Bogos K; Tímár J
    Pathol Oncol Res; 2006; 12(4):243-6. PubMed ID: 17189989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma.
    Einama T; Ueda S; Tsuda H; Ogasawara K; Hatsuse K; Matsubara O; Todo S; Yamamoto J
    Exp Ther Med; 2012 Jun; 3(6):931-936. PubMed ID: 22969995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproducibility crisis: Blame it on the antibodies.
    Baker M
    Nature; 2015 May; 521(7552):274-6. PubMed ID: 25993940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.